hAChE-IN-3 is used in Alzheimer's disease-related research due to its ability to inhibit AChE, BuChE, MAO-B, and BACE-1; its antioxidant activity and metal-chelating properties; and its capacity to bind to the peripheral anionic site, thereby modulating amyloid-β (Aβ) aggregation and reducing Alzheimer's disease-associated neurodegeneration.